Breadcrumb

null

COMPAR-EU RCTs Web

Bronchial asthma and COPD: Impact of pharmaceutical care on outcomes and quality of life in Egyptian patients

Author: Ebid, A. H. Country/countries: Egypt Number of patients participating in the study: 150 This study was focused on patients living with COPD
Intervention analysed in the study: Usual Care Plus Intervention components: UCP
See more
Setting of implementation: N/A Professionals delivering the intervention: N/A Targeted self-management behaviours: N/A
Intervention analysed in the study: Monitoring and action-based behavioural techniques delivered in groups Intervention components: E+MT+AB+G
See more
Setting of implementation: Outpatient care (hospital) Professionals delivering the intervention: Pharmacists Targeted self-management behaviours: Condition-specific behaviours, Medication use and adherence, Self-monitoring, Smoking cessation or reduction

Outcomes measured in the study

Outcome Measure Tool
COPD symptoms (short term) General COPD symptoms N/A
Lung Function FEV1 (% pred) - forced expiratory volume N/A
Number of emergency room visits and admissions Emergency room/department visits N/A

Patient characteristics

Age: 59.15 years (+/- a standard deviation of 15.05) Gender: N/A Time since diagnosis of COPD: N/A Severity of the disease: 60.5 (+/- a standard deviation of 20.46) Multi-morbidity: N/A
  • Number of co-morbidities: N/A

Level of health literacy: N/A
  • Tool: N/A

Socio-economic characteristics: N/A

Risk of Bias of this study

Outcome Random sequence generation Allocation concealment Blinding performance Blinding detection objective outcomes assessment Attrition incomplete outcome Incorrect statistical methods Recruitment bias Selective outcome reporting
COPD symptoms (short term) - General COPD symptoms
Lung Function - FEV1 (% pred) - forced expiratory volume
Number of emergency room visits and admissions - Emergency room/department visits
Number of emergency room visits and admissions - Emergency room/department visits